Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | decreases expression | ISO | Ube2w (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of UBE2W mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | decreases expression | ISO | Ube2w (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of UBE2W mRNA | CTD | PMID:22206623 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Ube2w (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Ube2w (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,4,6-trinitrobenzenesulfonic acid | decreases expression | ISO | Ube2w (Mus musculus) | 6480464 | Trinitrobenzenesulfonic Acid results in decreased expression of UBE2W mRNA | CTD | PMID:17982090 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of UBE2W mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of UBE2W mRNA | CTD | PMID:28628672 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Ube2w (Mus musculus) | 6480464 | Fenretinide results in decreased expression of UBE2W mRNA | CTD | PMID:28973697 | 4-phenylbutyric acid | decreases expression | EXP | | 6480464 | 4-phenylbutyric acid results in decreased expression of UBE2W mRNA | CTD | PMID:14583596 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of UBE2W mRNA | CTD | PMID:33167477 | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of UBE2W mRNA | CTD | PMID:24449571 | atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of UBE2W mRNA | CTD | PMID:22378314 | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of UBE2W gene | CTD | PMID:31601247 | cadmium dichloride | increases expression | ISO | Ube2w (Mus musculus) | 6480464 | Cadmium Chloride results in increased expression of UBE2W mRNA | CTD | PMID:20061341 | casticin | decreases expression | ISO | Ube2w (Mus musculus) | 6480464 | casticin results in decreased expression of UBE2W mRNA | CTD | PMID:28444820 | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to UBE2W gene] | CTD | PMID:28238834 | clorgyline | increases expression | EXP | | 6480464 | Clorgyline results in increased expression of UBE2W mRNA | CTD | PMID:19691856 | copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of UBE2W mRNA | CTD | PMID:20971185 | copper atom | increases expression | ISO | Ube2w (Mus musculus) | 6480464 | Copper results in increased expression of UBE2W mRNA | CTD | PMID:16629173 | copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of UBE2W mRNA | CTD | PMID:20971185 | copper(0) | increases expression | ISO | Ube2w (Mus musculus) | 6480464 | Copper results in increased expression of UBE2W mRNA | CTD | PMID:16629173 | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of UBE2W mRNA | CTD | PMID:19549813 | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2W mRNA | CTD | PMID:19167446 | coumestrol | decreases expression | EXP | | 6480464 | Coumestrol results in decreased expression of UBE2W mRNA | CTD | PMID:19167446 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of UBE2W mRNA | CTD | PMID:25562108 | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of UBE2W mRNA | CTD | PMID:28628672 | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of UBE2W mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Enterolactone | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2W mRNA | CTD | PMID:19167446 | fenofibrate | increases expression | ISO | Ube2w (Mus musculus) | 6480464 | Fenofibrate results in increased expression of UBE2W mRNA | CTD | PMID:21318169 | folic acid | decreases expression | ISO | Ube2w (Mus musculus) | 6480464 | Folic Acid results in decreased expression of UBE2W mRNA | CTD | PMID:25629700 | glyphosate | affects methylation | EXP | | 6480464 | Glyphosate affects the methylation of UBE2W gene | CTD | PMID:35377194 | glyphosate | multiple interactions | EXP | | 6480464 | [Glyphosate results in increased abundance of aminomethylphosphonic acid (AMPA)] which affects the methylation of UBE2W gene | CTD | PMID:35377194 | gold atom | decreases expression | EXP | | 6480464 | Gold results in decreased expression of UBE2W mRNA | CTD | PMID:25523186 | gold(0) | decreases expression | EXP | | 6480464 | Gold results in decreased expression of UBE2W mRNA | CTD | PMID:25523186 | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of UBE2W mRNA | CTD | PMID:28628672 | isotretinoin | decreases expression | EXP | | 6480464 | Isotretinoin results in decreased expression of UBE2W mRNA | CTD | PMID:20436886 | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of UBE2W mRNA | CTD | PMID:28988120 | leflunomide | increases expression | ISO | Ube2w (Mus musculus) | 6480464 | leflunomide results in increased expression of UBE2W mRNA | CTD | PMID:19751817 | methotrexate | increases expression | EXP | | 6480464 | Methotrexate results in increased expression of UBE2W mRNA | CTD | PMID:24449571 | methylmercury chloride | increases expression | ISO | Ube2w (Mus musculus) | 6480464 | methylmercuric chloride results in increased expression of UBE2W mRNA | CTD | PMID:20061341 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of UBE2W mRNA | CTD | PMID:28001369 | PCB138 | multiple interactions | ISO | Ube2w (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | potassium dichromate | decreases expression | ISO | Ube2w (Mus musculus) | 6480464 | Potassium Dichromate results in decreased expression of UBE2W mRNA | CTD | PMID:23608068 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silver atom | increases expression | EXP | | 6480464 | Silver results in increased expression of UBE2W mRNA | CTD | PMID:26014281 | silver(0) | increases expression | EXP | | 6480464 | Silver results in increased expression of UBE2W mRNA | CTD | PMID:26014281 | sodium arsenate | decreases expression | ISO | Ube2w (Mus musculus) | 6480464 | sodium arsenate results in decreased expression of UBE2W mRNA | CTD | PMID:21795629 | sodium arsenate | increases expression | ISO | Ube2w (Mus musculus) | 6480464 | sodium arsenate results in increased expression of UBE2W mRNA | CTD | PMID:21795629 | sodium arsenite | decreases methylation | ISO | Ube2w (Mus musculus) | 6480464 | sodium arsenite results in decreased methylation of UBE2W gene | CTD | PMID:32068019 | testosterone enanthate | affects expression | EXP | | 6480464 | testosterone enanthate affects the expression of UBE2W mRNA | CTD | PMID:17440010 | torcetrapib | increases expression | EXP | | 6480464 | torcetrapib results in increased expression of UBE2W mRNA | CTD | PMID:23228038 | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of UBE2W mRNA | CTD | PMID:26272509 | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2W mRNA | CTD | PMID:27188386 | troglitazone | increases expression | ISO | Ube2w (Mus musculus) | 6480464 | troglitazone results in increased expression of UBE2W mRNA | CTD | PMID:28973697 | tungsten | increases expression | ISO | Ube2w (Mus musculus) | 6480464 | Tungsten results in increased expression of UBE2W mRNA | CTD | PMID:30912803 | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of UBE2W mRNA | CTD | PMID:28818685 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of UBE2W mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of UBE2W mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2W mRNA | CTD | PMID:27188386 | |